A shadow market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Investigational Drug Acquiring Traction Online
The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning effects. Followers are urged to contact these accounts directly for supplier links, while also receiving discount codes.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Experts Voice Concerns
However, physicians and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users injecting substances of uncertain source.
Some experts said the popularity for retatrutide could be linked to the increasing cost of approved slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or distributed for human use under the British medical regulations.
Some content creators attempt to sidestep the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer laws, risking fines, legal action or prison.
Platform Reaction and Content Removal
Based on TikTok, the service has removed violative content and banned related hashtags and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with photos of weight loss, positive reviews and detailed guides for mixing or injecting at residence.
Within minutes of entering one group, a seller shared contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about body mass, medical conditions or past usage.
Item Information and Costs
Within these groups, posts show dark colored parcels with postal service stickers, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or pre-filled injectors usually sold at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Measures
A spokesperson for Telegram said it actively moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to social media. But fake injections are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has already encountered individuals harmed by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A spokesperson from the pharmaceutical company said the substance was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to potentially serious health risks”.
